About 20% of patients receiving hemodialysis (HD) show clinical signs of major depressive disorder (MDD). However, end-stage renal disease (ESRD) or HD are often exclusion criteria for clinical studies. Due to that, publications regarding treatment efficacy and pharmacokinetics are rare for this population.
No takes yet. Share an insight, caveat, or question.
Broen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: